Filters
For adults treated for persistent atrial fibrillation (AF), drinking a cup of coffee every day does not trigger AF recurrence or atrial flutter and even appears to reduce its incidence, according to the DECAF trial.
For individuals who sustained herpes zoster infection, prior receipt of recombinant zoster vaccine appears to reduce the long-term risks of major adverse cardiovascular events, dementia, and death, according to a retrospective study.
Daily accumulated steps in longer bouts appear to result in lower mortality and cardiovascular disease (CVD) risks than steps accumulated in shorter bouts among suboptimally active adults, reveals a study.
For multiethnic Southeast Asian patients with acute coronary syndrome (ACS), bleeding outcomes including BARC type 3 bleeding appear to be less favourable with ticagrelor than with clopidogrel, as shown in a retrospective study from Singapore.
Drug-coated balloon (DCB) angioplasty with rescue stenting in patients with de novo coronary artery disease (CAD) results in a higher rate of device-oriented composite endpoint (DoCE) than intended drug-eluting stent (DES) implantation at 3 years, reports a study.
Restricting sugar exposure in utero and during infancy appears protective against the risks of several cardiovascular outcomes and delays disease onset later in life, suggests a study.
Previous analyses found that body weight reduction does not predict the cardiorenal benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; eg, semaglutide). A pooled post-hoc analysis of the SUSTAIN 6 and PIONEER 6 trials demonstrated that semaglutide improved cardiorenal outcomes in a diverse population of patients with type 2 diabetes (T2D), regardless of prior history of cardiovascular disease (CVD) and baseline body mass index (BMI). The CV benefit remained consistent even when accounting for various degrees of weight loss.
Taking olive oil extract (OLE) helps lower 24-h blood pressure (BP), BP load (BPL), and diastolic BP variability (BPV) while improving lipid profile, systemic inflammation, and body weight in individuals with hypertension, a study has shown.
The morning home blood pressure (BP) control status seems to influence the association between left ventricular hypertrophy (LVH) and cardiovascular disease (CVD) risk, suggests a study.
Treatment with rivaroxaban appears to improve portal hypertension (PHT)-related complications without increasing the risk of major bleeding in patients with cirrhosis and moderate liver dysfunction, a study has shown.
